{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T07:10:34Z","timestamp":1766733034624,"version":"3.41.2"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T00:00:00Z","timestamp":1744934400000},"content-version":"vor","delay-in-days":107,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"GSK Investigator-Sponsored Studies"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To determine factors associated with reports of EuroQol 5-Dimensions (EQ-5D) full health state (FHS) before and after a trial intervention in patients with SLE, resorting to machine learning algorithms.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a post hoc analysis of two phase 3 clinical trials of belimumab (BLISS-52, BLISS-76). Demographic, laboratory and clinical features were retrieved and the Monte Carlo Feature Selection algorithm was employed, then further refined upon consideration of collinearity and clinical relevance. We used support vector machine with radial basis function kernel (SVMRadial), least absolute shrinkage and selection operator (LASSO), neural network (NNet) and logistic regression (LR) to capture both linear and non-linear relationships while ensuring interpretability and robustness.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among 1642 SLE patients, 12.9% reported FHS at baseline and 23.1% at week 52. Selected features were age, sex, Asian ancestry, baseline cSLEDAI-2K, SELENA-SLEDAI PGA, and urine protein:creatinine ratio (UPCR) and baseline EQ-5D 3-Levels (EQ-5D-3L) index score (week 52 models only). The models predicting FHS demonstrated comparable performance at baseline and week 52. A maximum area under the curve of 0.73 was seen for the baseline LASSO and LR models and a maximum of 0.77 for the week 52 LASSO and NNet models. Negative predictive values were high for all models (0.88\u20130.94). Calibration showed marginal improvement in week 52 models.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Machine learning identified older age, female sex, non-Asian ancestry, high disease activity and low UPCR to be associated with a lack of FHS experience in SLE patients at baseline and week 52. High baseline EQ-5D-3L index scores constituted the strongest predictor of FHS at week 52.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration<\/jats:title>\n                  <jats:p>The BLISS-52 and BLISS-76 trials are registered at www.clinicaltrials.gov (NCT00424476 and NCT00410384, respectively).<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rap\/rkaf032","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T17:01:38Z","timestamp":1744995698000},"source":"Crossref","is-referenced-by-count":1,"title":["Predicting EQ-5D full health state in systemic lupus erythematosus using machine learning algorithms"],"prefix":"10.1093","volume":"9","author":[{"given":"Jo\u00e3o","family":"Botto","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet , Stockholm,","place":["Sweden"]},{"name":"Department of Gastroenterology, Dermatology and Rheumatology, Karolinska University Hospital , Stockholm,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nursen","family":"Cetrez","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet , Stockholm,","place":["Sweden"]},{"name":"Department of Gastroenterology, Dermatology and Rheumatology, Karolinska University Hospital , Stockholm,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dionysis","family":"Nikolopoulos","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet , Stockholm,","place":["Sweden"]},{"name":"Department of Gastroenterology, Dermatology and Rheumatology, Karolinska University Hospital , Stockholm,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malin","family":"Regardt","sequence":"additional","affiliation":[{"name":"Department of Neurobiology, Care Sciences and Society, Division of Occupational Therapy, Karolinska Institutet , Stockholm,","place":["Sweden"]},{"name":"Women\u2019s Health and Allied Health Professionals Theme, Medical Unit Occupational Therapy and Physiotherapy, Karolinska University Hospital , Stockholm,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emelie","family":"Heintz","sequence":"additional","affiliation":[{"name":"Department of Learning, Informatics, Management and Ethics (LIME), Karolinska Institutet , Stockholm,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1582-9471","authenticated-orcid":false,"given":"Julius","family":"Lindblom","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet , Stockholm,","place":["Sweden"]},{"name":"Department of Gastroenterology, Dermatology and Rheumatology, Karolinska University Hospital , Stockholm,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4875-5395","authenticated-orcid":false,"given":"Ioannis","family":"Parodis","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet , Stockholm,","place":["Sweden"]},{"name":"Department of Gastroenterology, Dermatology and Rheumatology, Karolinska University Hospital , Stockholm,","place":["Sweden"]},{"name":"Department of Rheumatology, Faculty of Medicine and Health, \u00d6rebro University , \u00d6rebro,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,4,18]]},"reference":[{"key":"2025052701322594600_rkaf032-B1","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41584-021-00668-1","article-title":"Global epidemiology of systemic lupus erythematosus","volume":"17","author":"Barber","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"2025052701322594600_rkaf032-B2","doi-asserted-by":"crossref","first-page":"e000640","DOI":"10.1136\/lupus-2021-000640","article-title":"Real-world burden of systemic lupus erythematosus in the USA: a comparative cohort study from the Medical Expenditure Panel Survey (MEPS) 2016\u20132018","volume":"9","author":"Shannon","year":"2022","journal-title":"Lupus Sci Med"},{"key":"2025052701322594600_rkaf032-B3","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1177\/0961203306071710","article-title":"A review of health related quality of life in systemic lupus erythematosus","volume":"15","author":"McElhone","year":"2006","journal-title":"Lupus"},{"key":"2025052701322594600_rkaf032-B4","first-page":"1706","article-title":"How does quality of life of patients with systemic lupus erythematosus compare with that of other common chronic illnesses?","volume":"32","author":"Jolly","year":"2005","journal-title":"J Rheumatol"},{"key":"2025052701322594600_rkaf032-B5","doi-asserted-by":"crossref","first-page":"651249","DOI":"10.3389\/fmed.2021.651249","article-title":"Adverse health-related quality of life outcome despite adequate clinical response to treatment in systemic lupus erythematosus","volume":"8","author":"Gomez","year":"2021","journal-title":"Front Med"},{"key":"2025052701322594600_rkaf032-B6","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1177\/0961203316652494","article-title":"Patient-reported outcomes in lupus clinical trials with biologics","volume":"25","author":"Annapureddy","year":"2016","journal-title":"Lupus"},{"key":"2025052701322594600_rkaf032-B7","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1191\/096120399680411362","article-title":"Discordance between patients and their physicians in the assessment of lupus disease activity: relevance for clinical trials","volume":"8","author":"Yen","year":"1999","journal-title":"Lupus"},{"key":"2025052701322594600_rkaf032-B8","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1191\/096120300678828424","article-title":"Endpoints: consensus recommendations from OMERACT IV","volume":"9","author":"Strand","year":"2000","journal-title":"Lupus"},{"key":"2025052701322594600_rkaf032-B9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-0-387-78665-0_5","volume-title":"Handbook of disease burdens and quality of life measures","author":"Gusi","year":"2010"},{"key":"2025052701322594600_rkaf032-B10","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3899\/jrheum.081022","article-title":"Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus","volume":"36","author":"Aggarwal","year":"2009","journal-title":"J Rheumatol"},{"volume-title":"EQ-5D-3L user guide","year":"2018","author":"EuroQol Research Foundation","key":"2025052701322594600_rkaf032-B11"},{"key":"2025052701322594600_rkaf032-B12","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.3390\/life13071496","article-title":"Current treatment approach, emerging therapies and new horizons in systemic lupus erythematosus","volume":"13","author":"Athanassiou","year":"2023","journal-title":"Life"},{"key":"2025052701322594600_rkaf032-B13","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1093\/rheumatology\/keab080","article-title":"EQ-5D-3L full health state discriminates between drug and placebo in clinical trials of systemic lupus erythematosus","volume":"60","author":"Lindblom","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2025052701322594600_rkaf032-B14","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(10)61354-2","article-title":"Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial","volume":"377","author":"Navarra","year":"2011","journal-title":"Lancet"},{"key":"2025052701322594600_rkaf032-B15","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1002\/art.30613","article-title":"A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus","volume":"63","author":"Furie","year":"2011","journal-title":"Arthritis Rheum"},{"key":"2025052701322594600_rkaf032-B16","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2025052701322594600_rkaf032-B17","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1056\/NEJMoa051135","article-title":"Combined oral contraceptives in women with systemic lupus erythematosus","volume":"353","author":"Petri","year":"2005","journal-title":"N Engl J Med"},{"key":"2025052701322594600_rkaf032-B18","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","article-title":"Derivation of the SLEDAI. A disease activity index for lupus patients","volume":"35","author":"Bombardier","year":"1992","journal-title":"Arthritis Rheum"},{"key":"2025052701322594600_rkaf032-B19","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J Rheumatol"},{"key":"2025052701322594600_rkaf032-B20","first-page":"1934","article-title":"The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus","volume":"31","author":"Uribe","year":"2004","journal-title":"J Rheumatol"},{"key":"2025052701322594600_rkaf032-B21","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1093\/rheumatology\/keaa383","article-title":"Use of physician global assessment (PGA) in systemic lupus erythematosus: a systematic review of its psychometric properties","volume":"59","author":"Elisabetta","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2025052701322594600_rkaf032-B22","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/art.1780390303","article-title":"The development and initial validation of the Systemic Lupus International Collaborating Clinics\/American College of Rheumatology damage index for systemic lupus erythematosus","volume":"39","author":"Gladman","year":"1996","journal-title":"Arthritis Rheum"},{"key":"2025052701322594600_rkaf032-B23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00005650-200503000-00003","article-title":"US valuation of the EQ-5D health states: development and testing of the D1 valuation model","volume":"43","author":"Shaw","year":"2005","journal-title":"Med Care"},{"key":"2025052701322594600_rkaf032-B24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v085.i12","article-title":"rmcfs: an R package for Monte Carlo feature selection and interdependency discovery","volume":"85","author":"Drami\u0144ski","year":"2018","journal-title":"J Stat Softw"},{"key":"2025052701322594600_rkaf032-B25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v028.i05","article-title":"Building predictive models in R using the caret package","volume":"28","author":"Kuhn","year":"2008","journal-title":"J Stat Softw"},{"key":"2025052701322594600_rkaf032-B26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.32614\/RJ-2014-008","article-title":"ROSE: a package for binary imbalanced learning","volume":"6","author":"Lunardon","year":"2014","journal-title":"R J"},{"key":"2025052701322594600_rkaf032-B27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: An open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinformatics"},{"key":"2025052701322594600_rkaf032-B28","doi-asserted-by":"crossref","first-page":"56","DOI":"10.25080\/Majora-92bf1922-00a","volume-title":"Proc 9th Python Sci Conf (scipy 2010)","author":"McKinney","year":"2010"},{"key":"2025052701322594600_rkaf032-B29","first-page":"2825","article-title":"Scikit-learn: machine learning in python","volume":"12","author":"Pedregosa","year":"2012","journal-title":"J Mach Learn Res"},{"key":"2025052701322594600_rkaf032-B30","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41586-020-2649-2","article-title":"Array programming with NumPy","volume":"585","author":"Harris","year":"2020","journal-title":"Nature"},{"key":"2025052701322594600_rkaf032-B31","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","article-title":"SciPy 1.0: fundamental algorithms for scientific computing in Python","volume":"17","author":"Virtanen","year":"2020","journal-title":"Nat Methods"},{"key":"2025052701322594600_rkaf032-B32","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1109\/MCSE.2007.55","article-title":"Matplotlib: a 2D graphics environment","volume":"9","author":"Hunter","year":"2007","journal-title":"Comput Sci Eng"},{"key":"2025052701322594600_rkaf032-B33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/ebmental-2020-300162","article-title":"TableOne: an online web application and R package for summarising and visualising data","volume":"23","author":"Agapios","year":"2020","journal-title":"Evid Based Mental Health"},{"key":"2025052701322594600_rkaf032-B34","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/0961203319828519","article-title":"The impact of SLE on health-related quality of life assessed with SF-36: a systemic review and meta-analysis","volume":"28","author":"Gu","year":"2019","journal-title":"Lupus"},{"key":"2025052701322594600_rkaf032-B35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejr.2018.07.003","article-title":"Clinical characteristics and health related quality of life (HRQoL) in Egyptian patients with systemic lupus erythematosus","volume":"41","author":"Gaballah","year":"2019","journal-title":"Egypt Rheumatol"},{"key":"2025052701322594600_rkaf032-B36","first-page":"A121","article-title":"P188 Assessment of disease activity and health related quality of life in patients with systemic lupus erythematosus at Kenyatta National Hospital","volume":"7","author":"Nyambane","year":"2020","journal-title":"Lupus Sci Med"},{"key":"2025052701322594600_rkaf032-B37","doi-asserted-by":"crossref","first-page":"e000161","DOI":"10.1136\/lupus-2016-000161","article-title":"Association of age with health-related quality of life in a cohort of patients with systemic lupus erythematosus: the Georgians Organized Against Lupus study","volume":"3","author":"Plantinga","year":"2016","journal-title":"Lupus Sci Med"},{"key":"2025052701322594600_rkaf032-B38","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3899\/jrheum.090778","article-title":"EQ-5D and SF-36 quality of life measures in systemic lupus erythematosus: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, and fibromyalgia","volume":"37","author":"Frederick","year":"2010","journal-title":"J Rheumatol"},{"key":"2025052701322594600_rkaf032-B39","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.berh.2013.07.009","article-title":"Fatigue, health-related quality of life and other patient-reported outcomes in systemic lupus erythematosus","volume":"27","author":"Schmeding","year":"2013","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2025052701322594600_rkaf032-B40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12865-017-0200-5","article-title":"Impact of disease activity on health-related quality of life in systemic lupus erythematosus\u2014a cross-sectional analysis of the Swiss Systemic Lupus Erythematosus Cohort Study (SSCS)","volume":"18","author":"Chaigne","year":"2017","journal-title":"BMC Immunol"},{"key":"2025052701322594600_rkaf032-B41","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1177\/09612033211027943","article-title":"Associations between physicians\u2019 global assessment of disease activity and patient-reported outcomes in patients with systemic lupus erythematosus: a longitudinal study","volume":"30","author":"Louthrenoo","year":"2021","journal-title":"Lupus"},{"key":"2025052701322594600_rkaf032-B42","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1093\/rheumatology\/ket171","article-title":"Predictors of self-reported health-related quality of life in systemic lupus erythematosus","volume":"52","author":"Kiani","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"2025052701322594600_rkaf032-B43","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrrheum.2016.137","article-title":"The global burden of SLE: prevalence, health disparities and socioeconomic impact","volume":"12","author":"Carter","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"2025052701322594600_rkaf032-B44","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1080\/1744666X.2018.1529566","article-title":"Factors affecting quality of life in patients with systemic lupus erythematosus: important considerations and potential interventions","volume":"14","author":"Elera-Fitzcarrald","year":"2018","journal-title":"Expert Rev Clin Immunol"},{"key":"2025052701322594600_rkaf032-B45","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/13548506.2011.554566","article-title":"Health-related quality of life in patients with systemic lupus erythematosus and proliferative lupus nephritis","volume":"16","author":"Daleboudt","year":"2011","journal-title":"Psychol Health Med"},{"key":"2025052701322594600_rkaf032-B46","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1093\/rheumatology\/kead140","article-title":"Sensitivity analysis of EQ-5D-3L index scores in terms of discriminative and known-groups validity in SLE: introducing Adequate Health State","volume":"62","author":"Hua","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"2025052701322594600_rkaf032-B47","doi-asserted-by":"crossref","first-page":"1092325","DOI":"10.3389\/fmed.2022.1092325","article-title":"EQ-5D full health state after therapy heralds reduced hazard to accrue subsequent organ damage in systemic lupus erythematosus","volume":"9","author":"Lindblom","year":"2022","journal-title":"Front Med"},{"key":"2025052701322594600_rkaf032-B48","first-page":"525","article-title":"The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosus","volume":"28","author":"Wang","year":"2001","journal-title":"J Rheumatol"},{"key":"2025052701322594600_rkaf032-B49","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/annrheumdis-2013-205139","article-title":"Treat-to-target in systemic lupus erythematosus: recommendations from an international task force","volume":"73","author":"van Vollenhoven","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2025052701322594600_rkaf032-B50","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1177\/0961203316660202","article-title":"Validation of an Argentine version of Lupus Quality of Life questionnaire","volume":"25","author":"Machado Escobar","year":"2016","journal-title":"Lupus"}],"container-title":["Rheumatology Advances in Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumap\/article-pdf\/9\/2\/rkaf032\/62945004\/rkaf032.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumap\/article-pdf\/9\/2\/rkaf032\/62945004\/rkaf032.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T05:32:40Z","timestamp":1748323960000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumap\/article\/doi\/10.1093\/rap\/rkaf032\/8115327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3,14]]}},"URL":"https:\/\/doi.org\/10.1093\/rap\/rkaf032","relation":{},"ISSN":["2514-1775"],"issn-type":[{"type":"electronic","value":"2514-1775"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2025]]},"article-number":"rkaf032"}}